Avidian Wealth Solutions, LLC Exelixis, Inc. Transaction History

Avidian Wealth Solutions, LLC

  • $1.98 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 05, 2021
SELL
$20.53 - $25.22 $431,540 - $530,124
-21,020 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$18.39 - $24.8 $201,830 - $272,180
10,975 Added 109.26%
21,020 $422,000
Q3 2020

Nov 06, 2020
BUY
$20.67 - $26.94 $207,630 - $270,612
10,045 New
10,045 $246,000

Others Institutions Holding EXEL

# of Institutions
460
Shares Held
246M
Call Options Held
1.7M
Put Options Held
1.02M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $7.11B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Avidian Wealth Solutions, LLC Portfolio

Follow Avidian Wealth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidian Wealth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avidian Wealth Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email